INSP supply chain intelligence for Inspire Medical Systems, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| MEDTRONIC | MEDTRONIC | 90% | In 2007, we entered into an assignment and license agreement with Medtronic pursuant to which Medtronic assigned certain patents and trademarks to us |
| LIVN | LivaNova PLC | 72% | coverage policies with all major national commercial payors. In terms of government program coverage, all seven MACs provide coverage of Inspire therapy when certain coverage criteria are met. Fee-fo… |
| LIVN | LivaNova PLC | 72% | Reciprocal relationship from LIVN graph: Reciprocal relationship from INSP graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from INSP graph: coverage policies with all major na… |
| NYXH | Nyxoah SA | 72% | coverage policies with all major national commercial payors. In terms of government program coverage, all seven MACs provide coverage of Inspire therapy when certain coverage criteria are met. Fee-fo… |
| NYXH | Nyxoah SA | 72% | Reciprocal relationship from NYXH graph: Reciprocal relationship from INSP graph: coverage policies with all major national commercial payors. In terms of government program coverage, all seven MACs … |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| USGOV-DEPARTMENT-OF-DEFENSE | USGOV-DEPARTMENT-OF-DEFENSE | 95% | USAspending awards from Department of Defense: $513,590 across 2 awards. W81K0022F0164 IMPLANTABLE PULSE GENERATOR; HT001422F0018 CONSUMABLES FOR INSPIRE THERAPY SYSTEM | Qwen corrected direction: Ex… |
| USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | 95% | USAspending awards from Department of Veterans Affairs: $568,537 across 8 awards. 36C24225P1279 IMPLANTS; 36C24226N0449 INSPIRE MEDICAL DEVICES; 36C24225P0593 PROSTHETIC ORDER - IMPLANT ITEMS | Qwen … |
| LIVN | LivaNova PLC | 72% | Reciprocal relationship from LIVN graph: Reciprocal relationship from INSP graph: coverage policies with all major national commercial payors. In terms of government program coverage, all seven MACs … |
| LIVN | LivaNova PLC | 72% | coverage policies with all major national commercial payors. In terms of government program coverage, all seven MACs provide coverage of Inspire therapy when certain coverage criteria are met. Fee-fo… |
| LLY | Eli Lilly and Company | 72% | Reciprocal relationship from LLY graph: Reciprocal relationship from INSP graph: ely $4.0 million in lost revenue opportunity, most of which we believe was recovered during the first half of 2024. We… |
| LLY | Eli Lilly and Company | 72% | ely $4.0 million in lost revenue opportunity, most of which we believe was recovered during the first half of 2024. We typically seek to maintain higher levels of inventory to protect ourselves from … |
| NYXH | Nyxoah SA | 72% | coverage policies with all major national commercial payors. In terms of government program coverage, all seven MACs provide coverage of Inspire therapy when certain coverage criteria are met. Fee-fo… |
| NYXH | Nyxoah SA | 72% | Reciprocal relationship from NYXH graph: Reciprocal relationship from INSP graph: Reciprocal relationship from NYXH graph: Reciprocal relationship from INSP graph: Reciprocal relationship from NYXH g… |
| MEDTRONIC-PUBLIC-LIMITED-COMPANY | MEDTRONIC-PUBLIC-LIMITED-COMPANY | 62% | mpanies and we have secured coverage policies with all major national commercial payors. 15 Table of Contents All seven MACs provide coverage of Inspire therapy when certain coverage criteria are met… |
| PAYKEL-HEALTHCARE-CORPORATION-LIMITED | PAYKEL-HEALTHCARE-CORPORATION-LIMITED | 62% | ed to lower the price we charge for our products, our gross margins will decrease, which could have a material adverse effect on our business, financial condition, and results of operations, and impa… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| INSP-DEBT-10303 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2018-12-31. |
| INSP-DEBT | Debt stack $29.6M | 90% | Market cache reports total debt of $29.6M. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| INSP-OWNER-BLACKROCK-INC | BlackRock, Inc. | 90% | 13F overlay lists BlackRock, Inc. as top holder; 307 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | 100.00 | 2 | |
| VEEV | Veeva Systems Inc. | 100.00 | 2 | |
| BYSI | BeyondSpring Inc. | 100.00 | 2 | |
| ACIU | AC Immune SA | 100.00 | 2 | |
| VNDA | Vanda Pharmaceuticals Inc. | 100.00 | 2 | |
| CRIS | Curis, Inc. | 100.00 | 2 | |
| ALEC | Alector, Inc. | 100.00 | 2 | |
| DSGN | Design Therapeutics, Inc. | 100.00 | 2 | |
| AXSM | Axsome Therapeutics, Inc. | 100.00 | 2 | |
| EDSA | Edesa Biotech, Inc. | 100.00 | 2 | |
| BIOA | BioAge Labs, Inc. | 100.00 | 2 | |
| CTNM | Contineum Therapeutics, Inc. | 100.00 | 2 | |
| FHTX | Foghorn Therapeutics Inc. | 100.00 | 2 | |
| FDMT | 4D Molecular Therapeutics, Inc. | 100.00 | 2 | |
| NVO | Novo Nordisk A/S | 100.00 | 2 | |
| DAWN | Day One Biopharmaceuticals Inc | 100.00 | 2 | |
| SDGR | Schrödinger, Inc. | 100.00 | 2 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 100.00 | 2 | |
| AKTS | Aktis Oncology, Inc. | 100.00 | 2 | |
| IMNM | Immunome, Inc. | 100.00 | 2 |